|
|
Post by harryx1 on Apr 2, 2015 8:49:46 GMT -5
I searched the forum but couldn't find the link anywhere so here it is... professional.diabetes.org/admin/UserFiles/Christa/CSS%20AtAGlanceforwebsite33115.pdfThe meeting of interest: SUNDAY, JUNE 7, 2015 6:45 p.m. - 9:00 p.m. 6:45 p.m. – 7:30 p.m. – Dinner 7:30 p.m. – 9:00 p.m. – Symposium Addressing Postprandial Glucose Excursions in T2DM with Inhaled Insulin Sponsored by MediKinetics Supported by an educational grant from Sanofi Contact: Katie McGowan Phone: 858-717-2940 Location: Westin Boston Waterfront, Harbor Ballroom A recently approved inhaled insulin provides a convenient prandial option that does not require multiple daily injections and more closely mimics prandial insulin secretions in healthy adults. The drug-device combination is a dry formulation of human insulin delivered through a small inhaler that is administered at the start of a meal. Join our symposium to learn more! |
|
|
|
Post by bradleysbest on Apr 6, 2015 16:05:48 GMT -5
Hopefully everything is a go by this time & this conference will help get the word out . pumper time, maybe Spiro & Baba can be Al's "pips"!
|
|
|
|
Post by joeypotsandpans on Apr 6, 2015 16:29:56 GMT -5
What would it take for SNY/MNKD to ask Sam/Amy/Spiro to spend a beautiful late spring weekend in Boston Harbor to speak to the old cronies that don't know what twitter or blogs are....probably just to ask and take care of the trip expenses but how far would that go in opening eyes/minds of many important attendees? The value would be immense IMO, maybe not equal to the testimonials at the ADCOM in front of the panel, but a close second perhaps? ....having said that, Amy's "nice Easter weekend with Afrezza" helped my finger hit the buy button today before the close.  |
|
|
|
Post by harryx1 on May 17, 2015 14:45:37 GMT -5
Exhibit Hall (Hall A) Sanofi's Booths 605 & 801 - Both booths are at the entrance. professional.diabetes.org/admin/UserFiles/0%20-%20Sean/Documents/15_sci_ses_exhibit_hallA_2.pdf www.afassanoco.com/ada/currentexhibitors.pdfProduct Theaters professional.diabetes.org/admin/UserFiles/0%20-%20Sean/Documents/5_11_15%20ADA%202015%20Product%20Theater%20Copy.pdfSATURDAY, JUNE 6 10:15 a.m.-11:00 a.m. Afrezza®: An Alternate Insulin Delivery Sponsored by Sanofi Afrezza® is a new inhalable rapid acting insulin indicated to improve glycemic control in adults with type 1 and type 2 diabetes. The presentation is intended to familiarize clinicians with Afrezza® including efficacy and safety data from randomized clinical trials. Some additional topics to be covered include Afrezza® pharmacologic studies, dosing and titration guidance, and practical instructions on inhaler use will be also be reviewed. Presenter: Timothy Gilbert, MD Imperial Health Lake Charles, LA Location: Product Theater 2 (Booth 865) SUNDAY, JUNE 7 10:15 a.m.-11:00 a.m. Afrezza®: An Alternate Insulin Delivery Sponsored by Sanofi Afrezza® is a new inhalable rapid acting insulin indicated to improve glycemic control in adults with type 1 and type 2 diabetes. The presentation is intended to familiarize clinicians with Afrezza® including efficacy and safety data from randomized clinical trials. Some additional topics to be covered include Afrezza® pharmacologic studies, dosing and titration guidance, and practical instructions on inhaler use will be also be reviewed. Presenter: Timothy Gilbert, MD Imperial Health Lake Charles, LA Location: Product Theater 2 (Booth 865) |
|
|
|
Post by harryx1 on May 17, 2015 17:13:02 GMT -5
|
|
|
|
Post by kball on May 17, 2015 17:45:59 GMT -5
Nobody beats Harry. Nobody
|
|
|
|
Post by harryx1 on May 17, 2015 17:52:24 GMT -5
www.abstractsonline.com/pp8/#!/3699 If the above link doesn't work for you by clicking or highlighting it and right clicking and then selecting "open in new tab or window" then try below: To find the sessions/abstracts/etc, click on this link professional.diabetes.org/Congress_Display.aspx?TYP=9&CID=95010 then scroll down to the section "Online Itinerary Planner Now Available" and click on the link "online Itinerary Planner" (I think due to the dynamic nature of the site it would allow links to the exact places listed below).Late Breaking Abstracts: www.abstractsonline.com/pp8/#!/3699/presentation/12787 96-LB - Efficacy and Safety of Technosphere Inhaled Insulin: Systematic Review and Meta-analysis These are general sessions, but could talk about Afrezza. SESSION 3-CT-CI01 - Are They Really Worth It? Debating the Value of New Insulins in the Management of Type 2 Diabetes www.abstractsonline.com/pp8/#!/3699/session/119 Interesting.... SESSION 3-CT-SY03 - The Future Is Now—Leveraging Information Technology to Improve Diabetes Outcomes (Supported by a grant from The Leona M. and Harry B. Helmsley Charitable Trust) www.abstractsonline.com/pp8/#!/3699/session/121 3-CT-SY03 - Social Media June 7, 2015, 3:45 - 4:15 PM Authors Amy Tenderich, MA San Francisco, California
|
|
|
|
Post by liane on May 17, 2015 17:57:17 GMT -5
Harry,
Your links are not working.
|
|
|
|
Post by harryx1 on May 17, 2015 17:59:25 GMT -5
@liane, yes I know it looks like it's due to the "!", maybe you can check to see if that's a character not allowed in the hyperlink on the board. I've seen other characters in links have issues as well.
If it's something that can't be fixed then the workaround would be to highlight the entire link (URL) and then right click and then open in new tab.
|
|
|
|
Post by liane on May 17, 2015 18:05:19 GMT -5
Yeah, copying the entire link into a separate window works.
|
|
|
|
Post by yossarian on May 22, 2015 9:36:03 GMT -5
june 15
6:45 p.m. - 9:00 p.m.
6:45 p.m. – 7:30 p.m. – Dinner
7:30 p.m. – 9:00 p.m. – Symposium
Addressing Postprandial Glucose Excursions in T2DM with Inhaled Insulin
Sponsored by MediKinetics
Supported by an educational grant from Sanofi
Contact: Katie McGowan
Phone: 858-717-2940
Location: Westin Boston Waterfront, Harbor Ballroom
A recently approved inhaled insulin provides a convenient prandial option that does not require multiple
daily injections and more closely mimics prandial insulin secretions in healthy adults. The drug-device
combination is a dry formulation of human insulin delivered through a small inhaler that is administered
at the start of a meal. Join our symposium to learn more!...June 1599th 201
|
|
|
|
Post by als57 on May 22, 2015 12:43:11 GMT -5
That poster is what we need everywhere and when DTC starts what a great attention getter for a video clip! Great job!
|
|
|
|
Post by benh on May 28, 2015 16:02:18 GMT -5
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on May 28, 2015 17:35:14 GMT -5
You are killling me! Stop. Please. |
|
|
|
Post by Chris-C on May 28, 2015 17:46:33 GMT -5
I will be interested to see the abstract bodies posted, especially the one from board 96 (late breaking) on a meta-analysis of the safety and efficacy of Technosphere Insulin. My cursory search on Google Scholar found no other previous publications by Dr. Westcott, an internist, in the area of diabetes or metabolic disease. I hope he is presenting from the perspective of a clinician practicing evidence based medicine and I will be interested in his conclusions. Oddly, he is listed as being associated with Tufts Medical Center but does not appear in the clinical directory.
Chris-C
|
|
